Počet záznamů: 1  

Electrophoretic Delivery of Clinically Approved Anesthetic Drug for Chronic Pain Therapy

  1. 1.
    0575918 - ÚEB 2024 RIV US eng J - Článek v odborném periodiku
    Roy, A. - Bersellini Farinotti, A. - Arbring Sjöström, T. - Abrahamsson, T. - Cherian, D. - Karady, Michal - Tybrandt, K. - Nilsson, D. - Berggren, M. - Poxson, D. J. - Svensson, C. I. - Simon, D. T.
    Electrophoretic Delivery of Clinically Approved Anesthetic Drug for Chronic Pain Therapy.
    ADVANCED THERAPEUTICS. Roč. 6, č. 7 (2023), č. článku 2300083. E-ISSN 2366-3987
    Institucionální podpora: RVO:61389030
    Klíčová slova: anesthetic * bupivacaine * calcium imaging * drug delivery * electrophoretic * ion exchange membrane
    Obor OECD: Pharmacology and pharmacy
    Způsob publikování: Open access
    https://doi.org/10.1002/adtp.202300083

    Despite a range of available pain therapies, most patients report so-called “breakthrough pain.” Coupled with global issues like opioid abuse, there is a clear need for advanced therapies and technologies for safe and effective pain management. Here the authors demonstrate a candidate for such an advanced therapy: precise and fluid-flow-free electrophoretic delivery via organic electronic ion pumps (OEIPs) of the commonly used anesthetic drug bupivacaine. Bupivacaine is delivered to dorsal root ganglion (DRG) neurons in vitro. DRG neurons are a good proxy for pain studies as they are responsible for relaying ascending sensory signals from nociceptors (pain receptors) in the peripheral nervous system to the central nervous system. Capillary based OEIPs are used due to their probe-like and free-standing form factor, ideal for interfacing with cells. By delivering bupivacaine with the OEIP and recording dose versus response (Ca2+ imaging), it is observed that only cells close to the OEIP outlet (≤75 µm) are affected (“anaesthetized”) and at concentrations up to 10s of thousands of times lower than with bulk/bolus delivery. These results demonstrate the first effective OEIP deliveryof a clinically approved and widely used analgesic pharmaceutical, and thus are a major translational milestone for this technology.
    Trvalý link: https://hdl.handle.net/11104/0345609

     
    Název souboruStaženoVelikostKomentářVerzePřístup
    2023_Roy_ADVANCED THERAPEUTICS_2300083.pdf21.4 MBJinápovolen
     
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.